|
1
|
Inoue J, Ishida T, Tsukamoto N, et al:
Tumor necrosis factor receptor-associated factor (TRAF) family:
adapter proteins that mediate cytokine signaling. Exp Cell Res.
254:14–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arron JR, Walsh MC and Choi Y:
TRAF-mediated TNFR-family signaling. Curr Protoc Immunol. Nov
1–2002.Chapter 11(Unit 11): 9D View Article : Google Scholar
|
|
3
|
Xie P: TRAF molecules in cell signaling
and in human diseases. J Mol Signal. 8:72013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Keats JJ, Fonseca R, Chesi M, et al:
Promiscuous mutations activate the noncanonical NF-kappaB pathway
in multiple myeloma. Cancer Cell. 12:131–144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Namjou B, Choi CB, Harley IT, et al:
Evaluation of TRAF6 in a large multiancestral lupus cohort.
Arthritis Rheum. 64:1960–1969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zucchelli S, Codrich M, Marcuzzi F, et al:
TRAF6 promotes atypical ubiquitination of mutant DJ-1 and
alpha-synuclein and is localized to Lewy bodies in sporadic
Parkinson’s disease brains. Hum Mol Genet. 19:3759–3770.
2010.PubMed/NCBI
|
|
7
|
Kedinger V and Rio MC: TRAF4, the unique
family member. Adv Exp Med Biol. 597:60–71. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masson R, Regnier CH, Chenard MP, et al:
Tumor necrosis factor receptor associated factor 4 (TRAF4)
expression pattern during mouse development. Mech Dev. 71:187–191.
1998. View Article : Google Scholar
|
|
9
|
Kedinger V, Alpy F, Tomasetto C, et al:
Spatial and temporal distribution of the traf4 genes during
zebrafish development. Gene Expr Patterns. 5:545–552. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blaise S, Kneib M, Rousseau A, et al: In
vivo evidence that TRAF4 is required for central nervous system
myelin homeostasis. PLoS One. 7:e309172012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Regnier CH, Masson R, Kedinger V, et al:
Impaired neural tube closure, axial skeleton malformations, and
tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad
Sci USA. 99:5585–5590. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shiels H, Li X, Schumacker PT, et al:
TRAF4 deficiency leads to tracheal malformation with resulting
alterations in air flow to the lungs. Am J Pathol. 157:679–688.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cherfils-Vicini J, Vingert B, Varin A, et
al: Characterization of immune functions in TRAF4-deficient mice.
Immunology. 124:562–574. 2008. View Article : Google Scholar
|
|
14
|
Camilleri-Broët S, Cremer I, Marmey B, et
al: TRAF4 overexpression is a common characteristic of human
carcinomas. Oncogene. 26:142–147. 2007.PubMed/NCBI
|
|
15
|
Rhodes DR, Yu J, Shanker K, et al:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Regnier CH, Tomasetto C, Moog-Lutz C, et
al: Presence of a new conserved domain in CART1, a novel member of
the tumor necrosis factor receptor-associated protein family, which
is expressed in breast carcinoma. J Biol Chem. 270:25715–25721.
1995. View Article : Google Scholar
|
|
17
|
Bieche I, Tomasetto C, Regnier CH, et al:
Two distinct amplified regions at 17q11-q21 involved in human
primary breast cancer. Cancer Res. 56:3886–3890. 1996.PubMed/NCBI
|
|
18
|
Glauner H, Siegmund D, Motejadded H, et
al: Intracellular localization and transcriptional regulation of
tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4).
Eur J Biochem. 269:4819–4829. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kedinger V, Alpy F, Baguet A, et al: Tumor
necrosis factor receptor-associated factor 4 is a dynamic tight
junction-related shuttle protein involved in epithelium
homeostasis. PLoS One. 3:e35182008. View Article : Google Scholar
|
|
20
|
Yi P, Xia W, Wu RC, et al: SRC-3
coactivator regulates cell resistance to cytotoxic stress via
TRAF4-mediated p53 destabilization. Genes Dev. 27:274–287. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krajewska M, Krajewski S, Zapata JM, et
al: TRAF-4 expression in epithelial progenitor cells. Analysis in
normal adult, fetal, and tumor tissues. Am J Pathol. 152:1549–1561.
1998.PubMed/NCBI
|
|
22
|
Ye X, Mehlen P, Rabizadeh S, et al: TRAF
family proteins interact with the common neurotrophin receptor and
modulate apoptosis induction. J Biol Chem. 274:30202–30208. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takeshita F, Ishii KJ, Kobiyama K, et al:
TRAF4 acts as a silencer in TLR-mediated signaling through the
association with TRAF6 and TRIF. Eur J Immunol. 35:2477–2485. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Esparza EM and Arch RH: TRAF4 functions as
an intermediate of GITR-induced NF-kappaB activation. Cell Mol Life
Sci. 61:3087–3092. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abell AN and Johnson GL: MEKK4 is an
effector of the embryonic TRAF4 for JNK activation. J Biol Chem.
280:35793–35796. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zepp JA, Liu C, Qian W, et al: Cutting
edge: TNF receptor-associated factor 4 restricts IL-17-mediated
pathology and signaling processes. J Immunol. 189:33–37. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang WL, Wang J, Chan CH, et al: The E3
ligase TRAF6 regulates Akt ubiquitination and activation. Science.
325:1134–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gu X, Coates PJ, MacCallum SF, et al:
TRAF4 is potently induced by TAp63 isoforms and localised according
to differentiation in SCCHN. Cancer Biol Ther. 6:1986–1990. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rozan LM and El-Deiry WS: Identification
and characterization of proteins interacting with Traf4, an
enigmatic p53 target. Cancer Biol Ther. 5:1228–1235. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sax JK and El-Deiry WS: Identification and
characterization of the cytoplasmic protein TRAF4 as a
p53-regulated proapoptotic gene. J Biol Chem. 278:36435–36444.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rousseau A, McEwen AG,
Poussin-Courmontagne P, et al: TRAF4 is a novel
phosphoinositide-binding protein modulating tight junctions and
favoring cell migration. PLoS Biol. 11:e10017262013. View Article : Google Scholar
|
|
33
|
Wang X, Jin C, Tang Y, Tang LY and Zhang
YE: Ubiquitination of tumor necrosis factor receptor-associated
factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1
(Smurf1) regulates motility of breast epithelial and cancer cells.
J Biol Chem. 288:21784–21792. 2013. View Article : Google Scholar
|
|
34
|
Ahmed F, Shiraishi T, Vessella RL and
Kulkarni P: Tumor necrosis factor receptor associated factor-4: an
adapter protein overexpressed in metastatic prostate cancer is
regulated by microRNA-29a. Oncol Rep. 30:2963–2968. 2013.
|
|
35
|
Zhang L, Zhou F, Garcia de Vinuesa A, et
al: TRAF4 promotes TGF-β receptor signaling and drives breast
cancer metastasis. Mol Cell. 51:559–572. 2013.PubMed/NCBI
|
|
36
|
Li W, Peng C, Lee MH, et al: TRAF4 Is a
critical molecule for Akt activation in lung cancer. Cancer Res.
73:6938–6950. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brazil DP, Park J and Hemmings BA: PKB
binding proteins. Getting in on the Akt. Cell. 111:293–303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Manning BD and Cantley LC: AKT/PKB
signaling: navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu P, Cheng H, Roberts TM and Zhao JJ:
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev
Drug Discov. 8:627–644. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bose S, Chandran S, Mirocha JM and Bose N:
The Akt pathway in human breast cancer: a tissue-array-based
analysis. Mod Pathol. 19:238–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stal O, Perez-Tenorio G, Akerberg L, et
al: Akt kinases in breast cancer and the results of adjuvant
therapy. Breast Cancer Res. 5:R37–R44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hay N: The Akt-mTOR tango and its
relevance to cancer. Cancer Cell. 8:179–183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brazil DP and Hemmings BA: Ten years of
protein kinase B signalling: a hard Akt to follow. Trends Biochem
Sci. 26:657–664. 2001.PubMed/NCBI
|
|
44
|
Yang WL, Wu CY, Wu J and Lin HK:
Regulation of Akt signaling activation by ubiquitination. Cell
Cycle. 9:487–497. 2010.PubMed/NCBI
|
